COLUMBIA, Mo. – A new study says women diagnosed with early-stage breast cancer may be able to skip chemotherapy without risking their chances for survival.
Oncologists give women a risk score.
Until the release of the new study, though, there was a scientific gap in how to treat women who scored in the intermediate range with a score of 11 to 25.
The new findings could spare up to 70,000 American women per year diagnosed with early-stage breast cancer from the chemotherapy side effects.
Dr. Emily Albright, an MU healthcare surgical oncologist, says, “the recent results have clarified that for women at intermediate risk of recurrence, the majority of those do not benefit from chemotherapy. This saves those women the side effects of chemotherapy”.